Company Metagenomi, Inc.

Equities

MGX

US59102M1045

Biotechnology & Medical Research

Market Closed - Nasdaq 21:00:00 17/05/2024 BST 5-day change 1st Jan Change
7 USD 0.00% Intraday chart for Metagenomi, Inc. +6.87% 0.00%

Business Summary

Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed an expansive and modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. Its platform enables it to rapidly and effectively find, screen, and select tools with the highest targetability, specificity, and efficiency in order to develop them into genetic medicine.

Number of employees: 236

Sales per Business

USD in Million2022Weight2023Weight Delta
Ionis
49.0 %
0 0.7 % 22 49.0 % +19,466.96%
Moderna
40.5 %
15 84.4 % 18 40.5 % +24.80%
Affini-T
10.6 %
3 14.9 % 5 10.6 % +83.74%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
17 100.0 % 45 100.0 % +160.21%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 37,464,201 24,924,412 ( 66.53 %) 0 66.53 %

Shareholders

NameEquities%Valuation
BAYER AG
10.81 %
4,050,997 10.81 % 27 M $
3,179,294 8.484 % 21 M $
2,496,276 6.662 % 17 M $
Humboldt Capital LLC
5.061 %
1,896,445 5.061 % 13 M $
Sozo Ventures LLC
5.051 %
1,892,873 5.051 % 13 M $
RA Capital Management LP
4.655 %
1,744,415 4.655 % 12 M $
Novo Holdings A/S (Investment Company)
4.641 %
1,739,175 4.641 % 12 M $
1,707,473 4.557 % 12 M $
Farallon Capital Management LLC
3.585 %
1,343,201 3.585 % 9 M $
PFM Health Sciences LP
3.381 %
1,267,002 3.381 % 9 M $

Company contact information

Metagenomi, Inc.

5959 Horton Street 7th floor

94608, Emeryville

+

http://www.metagenomi.co
address Metagenomi, Inc.(MGX)
  1. Stock Market
  2. Equities
  3. MGX Stock
  4. Company Metagenomi, Inc.